NeuroOne Medical Technologies (NASDAQ:NMTC) Shares Down 9.1% – Time to Sell?

NeuroOne Medical Technologies Co. (NASDAQ:NMTC)’s stock price dropped 9.1% during trading on Thursday . The stock traded as low as $0.72 and last traded at $0.76. Approximately 393,704 shares were traded during trading, an increase of 196% from the average daily volume of 133,201 shares. The stock had previously closed at $0.84.

NeuroOne Medical Technologies Price Performance

The firm has a market capitalization of $23.53 million, a PE ratio of -1.59 and a beta of 0.54. The firm’s fifty day moving average is $0.83 and its two-hundred day moving average is $0.84.

Institutional Trading of NeuroOne Medical Technologies

A hedge fund recently raised its stake in NeuroOne Medical Technologies stock. Geode Capital Management LLC raised its stake in NeuroOne Medical Technologies Co. (NASDAQ:NMTC) by 9.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 283,855 shares of the company’s stock after buying an additional 24,972 shares during the period. Geode Capital Management LLC owned about 0.92% of NeuroOne Medical Technologies worth $281,000 at the end of the most recent quarter. 16.07% of the stock is owned by institutional investors and hedge funds.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.